(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TABRECTA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TABRECTA

ST13

US500000079281021

Class

5

Filing

79281021

Registration

6093318

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

01/22/2026

Trademark type

Word

Nice classes

5

Filing date

01/22/2020

Registration date

07/07/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/21/2026

Last transaction

01/22/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Basel, CH

Examiner

VAGHANI,MAYUR C

Current location

Historical data usage

Holders and representatives

Holders

NOVARTIS AG
NOVARTIS AG

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors ; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Publications

History of USPTO decisions and trademark events.

27 publications found

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

01/21/2026

71AG

REGISTERED-SEC.71 ACCEPTED

01/21/2026

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

01/15/2026

PR71

POST REGISTRATION ACTION MAILED - SEC.71

01/15/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/12/2026

ES71

TEAS SECTION 71 RECEIVED

08/29/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

07/07/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

12/08/2023

GPNX

NOTIFICATION PROCESSED BY IB

10/10/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/12/2020

FIMP

FINAL DISPOSITION PROCESSED

09/12/2020

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

08/06/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

07/07/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/06/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/06/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

05/06/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/06/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/06/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/06/2020

PUBO

PUBLISHED FOR OPPOSITION

04/21/2020

NPUB

NOTICE OF PUBLICATION

04/01/2020

MAFR

APPLICATION FILING RECEIPT MAILED

03/21/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/18/2020

DOCK

ASSIGNED TO EXAMINER

03/17/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/17/2020

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

03/16/2020

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

03/12/2020

Continuous trademark protection

Get notified about every new filing that threatens TABRECTA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.